Ligand Pharmaceuticals | LGND - Attività

Prezzo Delle Azioni
232.55
Cambio Giornaliero
0.25 0.11%
Mensile
13.38%
Annuale
120.18%
Q2 Previsione
222.71




Attività Cambiamento Data
Agenus USD 226.8M 7.09M 2025-12
Amgen USD 92.5B 1.92B 2026-03
Anika Therapeutics USD 179.39M 10.88M 2026-03
Arrowhead Research USD 1.6B 218.89M 2025-12
Baxter International USD 19.85B 209M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Enviri Corporation USD 2.71B 84.93M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Glaxosmithkline GBP 82.34B 102.25M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merck USD 128.68B 8.18B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.44B 30.38M 2026-03